James Edward Hoffman, MD

James E. Hoffman is an Assistant Professor of Clinical Medicine at Sylvester Comprehensive Cancer Center (SCCC), University of Miami School of Medicine. He is a specialist in plasma cell diseases, including multiple myeloma and amyloidosis and his clinical areas include myeloma, amyloidosis, POEMS, monoclonal gammopathy, MGUS and Waldentroms Macroglobulinemia. After completing a clinical fellowship in hematology-oncology at Memorial Sloan-Kettering Cancer Center, Hoffman joined the Cleveland Clinic in Florida, where he served as Director of the Outpatient Clinical Laboratory and as a hematologist/oncologist faculty member. He currently serves as Director of the myeloma and amyloidosis division and Associate Director of the hematology-oncology fellowship program at Sylvester.

A graduate of the Albert Einstein College of Medicine in New York, Hoffman completed his internship and residency in internal medicine at New York University Medical Center, where he served as chief medical resident. He earned his undergraduate degree from Columbia University.

Hoffman has received several awards, including the Fellow Teaching Award in 2007, and was awarded the Lymphoma Foundation’s Mortimer Lacher Research Fellowship grant, which supports fellows pursuing research of hematologic malignancies. He is board certified in Internal Medicine.

Representative Publications:
Selective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple Myeloma
Updated Survival Analysis of Two Sequential Prospective Trials of R-MACLO-IVAM Followed by Maintenance for Newly Diagnosed Mantle Cell Lymphoma
Severe Mononeuritis Multiplex After Rituximab in Igm-Κ Monoclonal Gammopathy
Lymphoma Associated Hemophagocytic Syndrome: It’s Going Viral